About Daniel
Daniel Wolf’s practice focuses on mergers and acquisitions where he represents public and private companies, as well as private equity firms, in a variety of domestic and international transactions. His transactional experience spans the range of M&A activity including many significant cross-border and contested transactions. He also counsels public company clients on governance, activism defense, finance, securities and other general corporate matters.In 2021, Daniel was recognized by International Financial Law Review (IFLR) as the U.S. Lawyer of the Year for M&A. He was named “Dealmaker of the Year” by The American Lawyer in 2020 and by the annual Deal Awards in 2019. His work in 2019 also earned him the distinction of being named #1 on MergerLinks’ list of the “Top M&A Lawyers in North America.” In the last ten consecutive years, Chambers and Partners listed Daniel as a top M&A attorney in Chambers USA. According to Chambers Global, one source noted him as an “exceptional lawyer” and “one of the smartest guys I have ever met.” From 2020–present, Daniel has been ranked in the “Hall of Fame” by The Legal 500 U.S. for M&A – Large Deals ($1BN+), the publication's highest individual ranking. He was recognized as a Leading Life Sciences Lawyer (Mergers & Acquisitions) by LMG, Life Sciences for 2021–2023. He is also recognized in Who’s Who Legal: M&A and Governance, was named an MVP by Law360, is listed as a New York Super Lawyer by Super Lawyers magazine in 2013–2022, and is endorsed by PLC’s Mergers and Acquisitions multi-jurisdictional guide.
Daniel Wolf’s practice focuses on mergers and acquisitions where he represents public and private companies, as well as private equity firms, in a variety of domestic and international transactions. His transactional experience spans the range of M&A activity including many significant cross-border and contested transactions. He also counsels public company clients on governance, activism defense, finance, securities and other general corporate matters.In 2021, Daniel was recognized by International Financial Law Review (IFLR) as the U.S. Lawyer of the Year for M&A. He was named “Dealmaker of the Year” by The American Lawyer in 2020 and by the annual Deal Awards in 2019. His work in 2019 also earned him the distinction of being named #1 on MergerLinks’ list of the “Top M&A Lawyers in North America.” In the last ten consecutive years, Chambers and Partners listed Daniel as a top M&A attorney in Chambers USA. According to Chambers Global, one source noted him as an “exceptional lawyer” and “one of the smartest guys I have ever met.” From 2020–present, Daniel has been ranked in the “Hall of Fame” by The Legal 500 U.S. for M&A – Large Deals ($1BN+), the publication's highest individual ranking. He was recognized as a Leading Life Sciences Lawyer (Mergers & Acquisitions) by LMG, Life Sciences for 2021–2023. He is also recognized in Who’s Who Legal: M&A and Governance, was named an MVP by Law360, is listed as a New York Super Lawyer by Super Lawyers magazine in 2013–2022, and is endorsed by PLC’s Mergers and Acquisitions multi-jurisdictional guide.
Daniel Wolf’s practice focuses on mergers and acquisitions where he represents public and private companies, as well as private equity firms, in a variety of domestic and international transactions. His transactional experience spans the range of M&A activity including many significant cross-border and contested transactions. He also counsels public company clients on governance, activism defense, finance, securities and other general corporate matters.
In 2021, Daniel was recognized by International Financial Law Review (IFLR) as the U.S. Lawyer of the Year for M&A. He was named “Dealmaker of the Year” by The American Lawyer in 2020 and by the annual Deal Awards in 2019. His work in 2019 also earned him the distinction of being named #1 on MergerLinks’ list of the “Top M&A Lawyers in North America.” In the last ten consecutive years, Chambers and Partners listed Daniel as a top M&A attorney in Chambers USA. According to Chambers Global, one source noted him as an “exceptional lawyer” and “one of the smartest guys I have ever met.” From 2020–present, Daniel has been ranked in the “Hall of Fame” by The Legal 500 U.S. for M&A – Large Deals ($1BN+), the publication's highest individual ranking. He was recognized as a Leading Life Sciences Lawyer (Mergers & Acquisitions) by LMG, Life Sciences for 2021–2023. He is also recognized in Who’s Who Legal: M&A and Governance, was named an MVP by Law360, is listed as a New York Super Lawyer by Super Lawyers magazine in 2013–2022, and is endorsed by PLC’s Mergers and Acquisitions multi-jurisdictional guide.
